Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia

Shuanglong Lu1, Anil Kumar Yadav1, Xiaohong Qiao1

  • 1Department of Pediatrics, Tongji Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Insights

MicroRNAs (miRNAs) and their target messenger RNAs (mRNAs) are implicated in acquired aplastic anemia (AA). This study identifies key miRNAs and mRNAs involved in T cell plasticity, offering insights into AA pathogenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) regulate T cell differentiation and plasticity by targeting messenger RNAs (mRNAs).
  • The roles of miRNAs and their target mRNAs in acquired aplastic anemia (AA) remain incompletely understood.
  • T cell dysfunction is a hallmark of various autoimmune diseases, including AA.

Purpose of the Study:

  • To investigate the regulatory roles of miRNAs and mRNAs in T cell differentiation and plasticity in acquired AA.
  • To identify key miRNA-mRNA interactions and networks dysregulated in acquired AA.
  • To elucidate the molecular mechanisms underlying T cell abnormalities in AA.

Main Methods:

  • Integrated analysis of Gene Expression Omnibus datasets from bone marrow T cells of acquired AA patients.
  • Identification of differentially expressed miRNAs (DE-miRNAs) and mRNAs (DE-mRNAs).
  • Construction of miRNA-mRNA networks using predicted targets and expression data, followed by pathway and network analyses.

Main Results:

  • 40 DE-miRNAs and 1511 DE-mRNAs were identified, with 303 negatively correlated miRNA-mRNA pairs.
  • Hsa-mir-34a-5p, hsa-mir-195-5p, and hsa-mir-424-5p emerged as potential central regulatory miRNAs.
  • Dysregulated mRNAs were significantly enriched in pathways related to T cell differentiation and plasticity, including histone gene regulation.

Conclusions:

  • A significant miRNA-mRNA regulatory network involved in T cell differentiation and plasticity was identified in acquired AA.
  • Hsa-mir-34a-5p, hsa-mir-195-5p, and hsa-mir-424-5p may play crucial roles in AA pathogenesis by targeting histone genes.
  • These findings highlight potential therapeutic targets for modulating T cell function in acquired AA.